Sargent Bickham Lagudis LLC - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 72 filers reported holding TRANSMEDICS GROUP INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Sargent Bickham Lagudis LLC ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q2 2022$138,000
+16.0%
4,4030.0%0.01%
+33.3%
Q1 2022$119,000
+41.7%
4,4030.0%0.01%
+50.0%
Q4 2021$84,000
-42.5%
4,4030.0%0.01%
-50.0%
Q3 2021$146,0000.0%4,4030.0%0.01%0.0%
Q2 2021$146,000
-20.2%
4,4030.0%0.01%
-25.0%
Q1 2021$183,0000.0%4,4030.0%0.02%
+100.0%
Q4 2020$183,0004,4030.01%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q4 2020
NameSharesValueWeighting ↓
Roubaix Capital, LLC 264,438$5,027,0004.84%
Abrams Capital Management 3,499,859$66,532,0002.07%
Sandhill Capital Partners LLC 736,175$13,995,0001.55%
EMERALD ADVISERS, LLC 451,542$8,584,0000.36%
RTW INVESTMENTS, LP 503,266$9,567,0000.36%
EMERALD MUTUAL FUND ADVISERS TRUST 429,868$8,172,0000.33%
NEXT CENTURY GROWTH INVESTORS LLC 107,045$2,034,0000.26%
ELEMENT CAPITAL MANAGEMENT LLC 63,175$1,201,0000.26%
HAMILTON LANE ADVISORS LLC 19,364$368,0000.16%
Harbour Capital Advisors, LLC 20,900$397,0000.15%
View complete list of TRANSMEDICS GROUP INC shareholders